Microbial fermentation of Fossence™, a short-chain fructo-oligosaccharide, under simulated human proximal colonic condition and assessment of its prebiotic effects-a pilot study.


Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
17 12 2021
Historique:
received: 19 07 2021
accepted: 24 11 2021
pubmed: 2 12 2021
medline: 8 1 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

A short-chain fructo-oligosaccharide (sc-FOS) was tested in a simulator of the human gut microbial ecosystem (SHIME) in vitro model to quantify its prebiotic effects according to Prebiotic Index (PI) and Measure of prebiotic effect (MPE) equations. FossenceTM, (sc-FOS, 0.5%) was fermented in a simulated human proximal colonic condition, using a fecal inoculum from a healthy individual. We analysed the pH reduction, substrate utilization, lactate and short-chain fatty acid (SCFA) production and microbial community modulation. Microbial fermentation of sc-FOS strongly reduced the media pH indicating the production of lactate and SCFA with accumulation of lactate and enhanced levels of acetate (34.38 ± 0.38 mM), propionate (20.93 ± 0.56 mM) and butyrate (4.93 ± 0.03 mM) compared to 18.46 ± 0.20 mM, 6.24 ± 0.10 mM and 3.3 ± 0.06 mM in the blank, respectively. Total SCFA production in test media was 61.91 ± 0.87 mM compared to 33.65 ± 0.36 mM in blank and the contribution of free-sugars present in sc-FOS to SCFAs was negligible. Modulation of the microbial community was analysed through 16S rRNA sequencing and we found that sc-FOS greatly stimulated the beneficial bacteria such as Bifidobacteria and Lactobacillus. We report the PI and MPE values for FossenceTM, as 14.9 and 0.01 respectively at the end of 24 h, which is an indicator of a strong prebiotic effect.

Identifiants

pubmed: 34849765
pii: 6442184
doi: 10.1093/femsle/fnab147
pii:
doi:

Substances chimiques

Fatty Acids, Volatile 0
Lactates 0
Oligosaccharides 0
Prebiotics 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of FEMS. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Deepika P Tiwari (DP)

Tata Chemicals Limited-Innovation Centre, Survey No 315, Hissa No 1-14, Ambedveth (V), Paud road, Mulshi, Pune 412111, Maharashtra, India.

Priyali Shah (P)

Tata Chemicals Limited-Innovation Centre, Survey No 315, Hissa No 1-14, Ambedveth (V), Paud road, Mulshi, Pune 412111, Maharashtra, India.

Pieter Van den Abbeele (P)

ProDigest BVBA, Technologiepark 3, 9052 Zwijnaarde, Gent, Belgium.

Massimo Marzorati (M)

ProDigest BVBA, Technologiepark 3, 9052 Zwijnaarde, Gent, Belgium.
Faculty of Bioscience Engineering, Center for Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium.

Marta Calatayud (M)

ProDigest BVBA, Technologiepark 3, 9052 Zwijnaarde, Gent, Belgium.
Faculty of Bioscience Engineering, Center for Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium.

Jonas Ghyselinck (J)

ProDigest BVBA, Technologiepark 3, 9052 Zwijnaarde, Gent, Belgium.

Ashok Kumar Dubey (AK)

Tata Chemicals Limited-Innovation Centre, Survey No 315, Hissa No 1-14, Ambedveth (V), Paud road, Mulshi, Pune 412111, Maharashtra, India.

S Narayanan (S)

Tata Chemicals Limited-Innovation Centre, Survey No 315, Hissa No 1-14, Ambedveth (V), Paud road, Mulshi, Pune 412111, Maharashtra, India.

Manish Jain (M)

Tata Chemicals Limited-Innovation Centre, Survey No 315, Hissa No 1-14, Ambedveth (V), Paud road, Mulshi, Pune 412111, Maharashtra, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH